Literature DB >> 31028192

Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer.

Ecaterina Carpenco1,2, Raluca Amalia Ceauşu3,4, Anca Maria Cimpean5,4, Puşa Nela Gaje3,4, Lilian Șaptefraţi1, Veaceslav Fulga1,2, Valeriu David2,2, Marius Raica3,4.   

Abstract

BACKGROUND/AIM: Mast cells (MCs) represent the most controversial non-malignant element of the tumor microenvironment. Our aim was to study how MCs density and distribution (intratumoral-MCit versus peritumoral-MCpt) relate to tumor grade and molecular subtypes.
MATERIALS AND METHODS: MCs tryptase immunohistochemistry was performed on 80 cases of breast carcinomas.
RESULTS: For Luminal A tumors, a partial correlation was detected between MCit and progesterone receptor (PR) (p=0.005). Luminal B tumors showed a significant correlation between MCpt and age (p=0.009), estrogen receptor (ER) (p=0.017) and PR (p=0.035). MCit and MCpt were strongly interrelated in this subtype (p=0.002) and in triple-negative breast cancers (p=0.002). In HER2 subtype, MCpt tumors were significantly correlated with HER2 (p=0.044). In G2 tumors, MCpt correlated with ER (p=0.015) and PR (p=0.038) while in G3 tumors ER correlated with both MCit (p=0.009) and MCpt (p=0.000487) tumors.
CONCLUSION: MCs dynamics are strongly influenced by hormone receptors and HER2 status. MCit increased in aggressive tumor types and is a worse prognostic factor. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; hormone receptors; mast cell; prognosis; tryptase; tumor grade

Mesh:

Substances:

Year:  2019        PMID: 31028192      PMCID: PMC6559908          DOI: 10.21873/invivo.11534

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  24 in total

Review 1.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

2.  Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

Authors:  Rico D Bense; Christos Sotiriou; Martine J Piccart-Gebhart; John B A G Haanen; Marcel A T M van Vugt; Elisabeth G E de Vries; Carolien P Schröder; Rudolf S N Fehrmann
Journal:  J Natl Cancer Inst       Date:  2016-10-13       Impact factor: 13.506

Review 3.  Mast cells in breast cancer angiogenesis.

Authors:  Anca Maria Cimpean; Roberto Tamma; Simona Ruggieri; Beatrice Nico; Alina Toma; Domenico Ribatti
Journal:  Crit Rev Oncol Hematol       Date:  2017-04-27       Impact factor: 6.312

4.  Mast cell tryptase promotes breast cancer migration and invasion.

Authors:  Meng Xiang; Yiping Gu; Fengdi Zhao; Hong Lu; Sifeng Chen; Lianhua Yin
Journal:  Oncol Rep       Date:  2010-03       Impact factor: 3.906

5.  Estrogen is an important mediator of mast cell activation in ovarian endometriomas.

Authors:  Tian-Hong Zhu; Shao-Jie Ding; Tian-Tian Li; Li-Bo Zhu; Xiu-Feng Huang; Xin-Mei Zhang
Journal:  Reproduction       Date:  2017-10-26       Impact factor: 3.906

6.  Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Authors:  Antonio C Wolff; M Elizabeth Hale Hammond; Kimberly H Allison; Brittany E Harvey; Pamela B Mangu; John M S Bartlett; Michael Bilous; Ian O Ellis; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Lisa M McShane; Mitchell Dowsett
Journal:  J Clin Oncol       Date:  2018-05-30       Impact factor: 44.544

7.  Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.

Authors:  Lei Li; Qiang Dang; Hongjun Xie; Zhao Yang; Dalin He; Liang Liang; Wenbing Song; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2015-06-10

8.  The associations between mast cell infiltration, clinical features and molecular types of invasive breast cancer.

Authors:  Jianfeng Sang; Dandan Yi; Xiaoqiao Tang; Yifen Zhang; Tao Huang
Journal:  Oncotarget       Date:  2016-12-06

Review 9.  Are Mast Cells MASTers in Cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Giancarlo Marone; Raffaella Iannone; Gianni Marone; Francescopaolo Granata
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 7.561

10.  Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals.

Authors:  Qun Rao; Yuan Chen; Chiuan-Ren Yeh; Jie Ding; Lei Li; Chawnshang Chang; Shuyuan Yeh
Journal:  Oncotarget       Date:  2016-02-16
View more
  6 in total

Review 1.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

2.  Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.

Authors:  Simona Sakalauskaitė; Vita Riškevičienė; Jakov Šengaut; Nomeda Juodžiukynienė
Journal:  Acta Vet Scand       Date:  2022-06-27       Impact factor: 2.048

3.  An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses.

Authors:  Angélica Aponte-López; Jennifer Enciso; Samira Muñoz-Cruz; Ezequiel M Fuentes-Pananá
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

Review 4.  Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role.

Authors:  Mark R Hanes; Carman A Giacomantonio; Jean S Marshall
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 5.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

Review 6.  Histamine in cancer immunology and immunotherapy. Current status and new perspectives.

Authors:  María de la Paz Sarasola; Mónica A Táquez Delgado; Melisa B Nicoud; Vanina A Medina
Journal:  Pharmacol Res Perspect       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.